ImmunoACT
ImmunoACT - Company Profile & Overview
Private
Private
2018
2018
Founded in 2018, ImmunoACT operates in Health Tech offering gene-modified cell therapies, specifically CAR-T cell therapy for treating certain B-cell malignancies. The company was spun out from IIT-Bo...
Funding stage:
Corporate Round
Last funding:
30/05/2023
Total funding:
$17.18 Mn+
Investors
Employee count:
183
Last 90d
183
Last 90d
Web traffic:
3.73K
3.73K
Last 30d
Last 30d
Glassdoor Rating: